Sign in with Google. Opens in new tab
ENTITY
Bayer

Bayer (BAYN GR)

69
Analysis
Health CareGermany
Bayer AG produces and markets healthcare and agricultural products. The Company manufactures products that include aspirin, antibiotics, anti-infectives, cardiovascular, oncology, central nervous system drugs, over-the-counter medications, diagnostics, and animal health products, as well as crop protection products, plastics, and polyurethanes.
more
bullishSillaJen Inc
03 Nov 2016 03:26

SillaJen IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I summarized the growth potential and appropriate valuation level of SillaJen.Apparently, not many people are doubtful...

Logo
332 Views
Share
02 Nov 2016 07:10

Winds Across the Pacific: What the US Election Will Bring to Asia

The bitter divisiveness of the campaign, between Democrat Hillary Clinton and her Republican rival Donald Trump, reflects the deep disaffection of...

Logo
231 Views
Share
20 Oct 2016 03:25

Recap of Key Events in the U.S. Biotechnology and Pharmaceutical Sector: Mid-Week Update

Galapagos NV (GLPG NA) seems to have got some investor attention after the successful results of Celgene Corp (CELG US) anti-inflammatory product...

bearishMonsanto Co
10 Oct 2016 16:27

Monsanto/Bayer Merger to Face Opposition in Africa

Bayer’s $66 billion bid for genetically modified seed and herbicide producer Monsanto faces strong opposition from a range of stakeholders in South...

Logo
208 Views
Share
01 Oct 2016 11:32

2016 US Elections Scenario Two: Donald Trump Wins

A US election fought under moderately favourable economic conditions, with a Republican electorate divided and openly unhappy with its...

Logo
266 Views
Share
x